Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of WT1 Expression as a Marker of Treatment Outcome in Karyotype Normal Acute Myeloid Leukemia Patients in Pakistan.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP - 1 May 2016

Ahmed Zeeshan Ansar, Shaikh Muhammad Shariq, Moatter Tariq

Abstract excerpt

Currently, there is an effort to predict relapse by follow-up monitoring of MRD and subsequently to begin the treatment of the patients during their clinical and hematological remission prior to overt hematological relapse. Expression of WT1 in AML is known to be independently associated with significant inferior response to therapy and short survival outcome. Follow-up monitoring of WT1 gene expression during or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Expression Regulation, Leukemic
Share to Karyotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm, Residual

Share to Pakistan

Share to Pilot Projects

Share to Recurrence

Share to Survival Rate

Share to WT1 Proteins

Source

Identifiers

PMID: 27225156
DOI: 2333

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of WT1 Expression as a Marker of Treatment Outcome in Karyotype Normal Acute Myeloid Leukemia Patients in Pakistan.PMID 27225156Read ↗

High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk.Semantic proximity Read ↗

Prognostic significance of WT1 expression at diagnosis and end of induction in Egyptian adult acute myeloid leukemia patients.Semantic proximity Read ↗

Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemiaSemantic proximity Read ↗

RNA Sequencing Identifies WT1 Overexpression as a Predictor of Poor Outcomes in Acute Myeloid LeukemiaSemantic proximity Read ↗

Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometrySemantic proximity Read ↗

Prognostic Impact of Wilms' Tumour 1 Mutation in Patients with Acute Myeloid Leukaemia.Semantic proximity Read ↗

Clinical features and prognosis of normal karyotype acute myeloid leukemia pediatric patients with WT1 mutations: an analysis based on TCGA database.Semantic proximity Read ↗

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patientsSemantic proximity Read ↗

Clinical significance of WT1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia.Semantic proximity Read ↗

Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype.Semantic proximity Read ↗

Prognostic impact of WT1 expression prior to hematopoietic stem cell transplantation in children with malignant hematological diseasesSemantic proximity Read ↗

Prognostic Significance of WT1 Expression Level Thershold in Acute Myeloid Leukemia Patients Receiving Hematopoietic Stem Cell Transplantation: Meta-AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.